Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 12,344.00
Ask: 12,346.00
Change: 68.00 (0.55%)
Spread: 2.00 (0.016%)
Open: 12,268.00
High: 12,388.00
Low: 12,256.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Down; US Accuses China Of Reneging On Trade

Tue, 07th May 2019 08:54

LONDON (Alliance News) - Stock prices in London opened lower on Tuesday after the US-China trade war threatened to reignite over the long bank holiday weekend in the UK. Top economics advisers to US President Donald Trump accused China of going back on promises made in an attempt to resolve their trade dispute and have vowed to implement fresh tariffs, US media reported on Monday."Over the course of the last week or so, we've seen an erosion in commitments by China, I would say retreating from commitments that have already been made," the Wall Street Journal quoted US Trade Representative Robert Lighthizer as saying.Lighthizer told reporters that the US would begin implementing a rise in tariffs on USD200 billion worth of Chinese goods from 10% to 25% from Friday.His comments came after Trump made an initial threat to China on Sunday, tweeting that talks were moving "too slowly" and that the Chinese were attempting to renegotiate."For 10 months, China has been paying Tariffs to the USA of 25% on 50 Billion Dollars of High Tech, and 10% on 200 Billion Dollars of other goods," Trump said in a tweet. "The 10% will go up to 25% on Friday".The FTSE 100 was down 22.23 points, or 0.3%, at 7,358.41 early Tuesday. The FTSE 250 index was down 27.12 points, or 0.1%, at 19,677.91, while the AIM All-Share was up 0.1% at 971.20.The Cboe UK 100 index was down 0.5% at 12,445.96. The Cboe UK 250 was down 0.2% at 17,641.98. The Cboe UK Small Companies was flat at 11,776.34.ThinkMarkets analyst Naeem Aslam said: "As the UK market was closed yesterday because of the bank holiday, traders will have to measure the Trump tactic very carefully. Looking at the last 24-hour market reaction, it becomes clear that traders do not really believe that Donald Trump is going to do what he said in his tweet. They believe this was nothing but just a tactic. "It has worked to an extent because the Chinese negotiators do understand the underlying risk better now. No one wants a [trade] war; it is not beneficial to the US, no matter how Trump sugarcoats this and it does not do any favours to the second biggest economy of the world." In Paris the CAC 40 was up 0.2% and the DAX 40 in Frankfurt was up 0.1%. In the FTSE 100, AstraZeneca was up 1.5% after the Anglo-Swedish drugmaker said its treatment for chronic lymphocytic leukaemia had met its primary goal of delivering an improvement in the time patients live without disease progression compared to an alternative combination treatment.Vodafone was up 1.1% after the telecommunications firm said it has signed a cable wholesale agreement with Telefonica Deutschland for Telefonica to offer broadband services via Vodafone's network in Germany. In the FTSE 250, Domino's Pizza Group was the worst performer, down 8.0% after the pizza delivery chain said it saw a robust performance in the first quarter, but international sales "remain disappointing". In the 13 weeks to March 31, group system sales rose 4.3% to GBP324.4 million from GBP311.1 million last year. In the UK and Republic of Ireland, system sales were up 4.8% at GBP299.3 million from GBP285.5 million. International system sales were down 2.0% at GBP25.1 million from GBP25.6 million in the first quarter last year. As such, the company said given persistently weak system sales in overseas markets, it no longer expects this part of the business to break-even this year.G4S was down 7.0% after the outsourcer said GardaWorld Security does not intend to make an offer for the company. G4S said it is to focus on separating its cash solutions business from the rest of the group as a means to create value for shareholders. On AIM, Purplebricks Group was down 4.5% after the online estate agent said Founder & Chief Executive Michael Bruce will step down immediately after a "disappointing" 12 months and will be replaced by Chief Operating Officer Vic Darvey.Purplebricks also said it is pulling out of Australia and placing its US business under review.In the US on Monday, Wall Street ended lower, with the Dow Jones Industrial Average down 0.3% and the S&P 500 and Nasdaq Composite down 0.5%.In China on Tuesday, the Shanghai Composite closed up 0.7%, while the Hang Seng index in Hong Kong is up 0.4%. Financial markets in Japan reopened on Tuesday after 10 days following the Golden Week holiday. The Nikkei 225 index closed down 1.5%.The pound was quoted at USD1.3124 early Tuesday, lower than USD1.3150 at the London equities close Friday.In political news, cross-party Brexit talks are set to continue this week as ministers urged Labour leader Jeremy Corbyn to do a deal with the government to break the impasse.Negotiations between Labour and the Conservatives will resume on Tuesday, with reports over the weekend suggesting UK Prime Minister Theresa May is poised to propose a temporary customs arrangement with the EU.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.